The Course of Renal Function before and during Antihypertensive Treatment in Diabetic Nephropathy

  • Hans-Henrik Parving
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


Approximately 40% of all insulin-dependent diabetic (IDDM) patients ultimately develop the clinical syndrome of diabetic nephropathy: persistent proteinuria associated with a decline in glomerular filtration rate (GFR) and elevated blood pressure [1–3]. This complication is the main cause of the increased morbidity and mortality in IDDM patients [4]. Renal failure due to nephropathy is the major cause of death (30%) in IDDM patients [2]. On average, death occurs 7 years after the start of persistent proteinuria. During the last decade, our knowledge with respect to prediction, development, progression, and treatment of diabetic nephropathy has increased tremendously. This chapter reviews renal function before and during antihypertensive treatment.


Glomerular Filtration Rate Diabetic Nephropathy Arterial Blood Pressure Antihypertensive Treatment IDDM Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Knowles HC: Magnitude of the renal failure problem in diabetes. Kidney Int 6: 2–7, 1974.Google Scholar
  2. 2.
    Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death and complications. Diabetologia 14: 363–370, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596, 1985.PubMedCrossRefGoogle Scholar
  5. 5.
    Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 28: 830–838, 1985.PubMedCrossRefGoogle Scholar
  6. 6.
    Viberti GC, Keen H, Mackintosh D: β2-Microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J 282: 95–98, 1981.CrossRefGoogle Scholar
  7. 7.
    Parving H-H, Andersen AR, Smidt UM: Monitoring progression of diabetic nephropathy. Ups J Med Sci 90: 15–23, 1985.PubMedCrossRefGoogle Scholar
  8. 8.
    Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457–461, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Bröchner-Mortensen J: Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 5: 1–17, 1985.PubMedCrossRefGoogle Scholar
  10. 10.
    Parving H-H, Andersen AR, Hommel E, Smidt UM: The effect of antihypertensive treatment on diabetic nephropathy in insulin-dependent diabetic patients. In: Friedman EA, L’Esperance FA (eds) Diabetic renal-retinal syndrome. New York: Grune and Stratton, 1984, pp 183–190.Google Scholar
  11. 11.
    Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36: 383–388, 1976.PubMedCrossRefGoogle Scholar
  12. 12.
    Jones RH, Rayakawa H, Mackay JD, Parsons V, Watkins PJ: Progression of diabetic nephropathy. Lancet 1: 1105–1106, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. Am J Med 74: 256–264, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Berglund J, Lins L-E, Lins P-E: Predictability in diabetic nephropathy. Acta Med Scand 215: 263–270, 1984.PubMedCrossRefGoogle Scholar
  15. 15.
    Reubi FC, Franz KA, Horber F: Hypertension as related to renal function in diabetes mellitus. Hypertension [Suppl 2] 7: 21–28, 1985.Google Scholar
  16. 16.
    Watkins PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malin JM, O’Sullivan DJ, Pinto JA: The natural history of diabetic renal disease. Q J Med 41: 437–456, 1972.PubMedGoogle Scholar
  17. 17.
    Mauer SM, Steffes MW, Ellis EM, Sutherland DER, Brown DM, Goetz FC: Structural—functional relationship in diabetic nephropathy. J Clin Invest 74: 1143–1155, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    Osterby R, Andersen AR, Gregersen G, Gundersen HJG, Hommel E, Horlyck A, Jorgensen HE, Lokkegârd H, Mogensen CE, Nyberg G, Parving H-H, Svalander C: Quantitative structural data on the development of diabetic nephropathy. Diabetic Nephropathy 5: 10–11, 1986.Google Scholar
  19. 19.
    Berglund J, Lins L-E, Lins P-E: Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 218: 401–408, 1985.PubMedCrossRefGoogle Scholar
  20. 20.
    Hasslacher Ch, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 28: 6–11, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Parving H-H, Andersen AR, Smidt UM, Oxenboll B, Edsberg B, Christiansen JS: Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12, 1983.PubMedCrossRefGoogle Scholar
  22. 22.
    Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688, 1982.CrossRefGoogle Scholar
  23. 23.
    Parving H-H, Andersen AR, Smidt UM, Svendsen PAa: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179, 1983.PubMedCrossRefGoogle Scholar
  24. 24.
    Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PAa: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447, 1987.CrossRefGoogle Scholar
  25. 25.
    Parving H-H, Andersen AR, Hommel-E, Smidt UM: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension [Suppy 2] 7: 114–117, 1985.Google Scholar
  26. 26.
    Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474, 1986.CrossRefGoogle Scholar
  27. 27.
    Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470, 1986.CrossRefGoogle Scholar
  28. 28.
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380, 1982.PubMedCrossRefGoogle Scholar
  29. 29.
    Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes. Kidney Int 19: 410–415, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Jensen PK, Christiansen JS, Steven K, Parving H-H: Renal function in streptozotocin diabetic rats. Diabetologia 21: 409–414, 1981.PubMedCrossRefGoogle Scholar
  31. 31.
    Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H: Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495, 1986.PubMedCrossRefGoogle Scholar
  32. 32.
    Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35–41, 1978.PubMedCrossRefGoogle Scholar
  33. 33.
    Hostetter TH, Olsson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241: 85–93, 1981.Google Scholar
  34. 34.
    Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647–655, 1983.PubMedCrossRefGoogle Scholar
  35. 35.
    Steffes MW, Brown DM, Mauer SM: The development, enhancement, and reversal of the secondary complications of diabetes mellitus. Hum Pathol 10: 293–299, 1979.PubMedCrossRefGoogle Scholar
  36. 36.
    Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM: The effect of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738–744, 1978.PubMedCrossRefGoogle Scholar
  37. 37.
    Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA: Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949, 1983.PubMedCrossRefGoogle Scholar
  38. 38.
    Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930, 1986.PubMedCrossRefGoogle Scholar
  39. 39.
    Bank N, Klose R, Aynedjian HS: Glomerular pressure in rats with diabetes and hypertension [abstr]. Kidney Int 27: 41, 1985.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Hans-Henrik Parving

There are no affiliations available

Personalised recommendations